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p53 hides a multitude of CIN
C
ells missegregate a chromosome 
approximately once every hun-
dred divisions. But don’t be too 
alarmed: Thompson and Compton report 
that the tumor suppressor p53 limits the 
growth of cells with incorrect numbers of 
chromosomes and prevents their progres-
sion toward cancer (1).
Tumor cells tend to missegregate 
chromosomes at a particularly high fre-
quency (a condition known as chro-
mosomal instability, or CIN), which is 
probably why they are often aneuploid 
(i.e., they carry an abnormal number of 
chromosomes). In 2008, Sarah Thompson 
and Duane Compton, from Dartmouth 
Medical School, Hanover, NH, revealed 
that most CIN in tumor cells was caused 
by incorrect attachments between mitotic 
spindle microtubules and kinetochores, 
and that inducing misattachments in nor-
mal cells was suffi  cient to generate high 
rates of chromosome missegregation (2). 
There was a small but signifi  cant wrinkle 
to this story, however: normal, diploid 
cells stopped proliferating as soon as 
they gained or lost a chromosome, so 
they never converted into a cancer-like 
aneuploid cell line.
“You can’t impose instability on a 
healthy, diploid cell and get an aneuploid 
population,” says Compton. Aneuploid 
tumor cells grow well, how-
ever, suggesting that they’ve 
learned to tolerate changes 
in chromosome number.
To investigate why 
normal cells stop prolifer-
ating when they missegre-
gate their DNA, Thompson 
and Compton engineered a 
human cell line to carry a 
unique fl  uorescent mark on 
one of its chromosomes. “This allowed 
us to identify and follow by live micros-
copy the cells that missegregated a chro-
mosome,” explains Compton.
The researchers induced missegre-
gation by either briefl  y treating the cells 
with the mitotic inhibitor monastrol or 
by depleting the mitotic kinesin motor 
MCAK, and then looked for cells that 
had gained or lost a fl  uorescent  mark 
within their genome. These cells failed 
to proliferate over the course of fi  ve 
days, and showed elevated levels of p53 
and one of its transcriptional targets, the 
cell cycle inhibitor p21. Cells lacking 
p53 became aneuploid after monastrol 
treatment or MCAK depletion, indicat-
ing that the p53 pathway normally serves 
to limit the propagation of cells with odd 
numbers of chromosomes.
How is p53 activated by chromo-
some missegregation? Thompson and 
Compton think that a change in chromo-
some number leads to an imbalance in 
gene expression, result-
ing in a stress response 
and cell cycle arrest that 
is vital to avoid cancer. 
“By combining loss of 
p53 with increased mis-
segregation rates, we can 
convert a diploid cell into 
something with a karyo-
type that looks like a 
tumor cell,” says Comp-
ton. Furthermore, these aneuploid cells 
develop an inherent genomic instabil-
ity reminiscent of genuine cancer cells. 
They are prone to further changes in 
chromosome number, perhaps because 
aneuploidy and imbalanced gene expres-
sion causes disruptions to mitosis.
A recent study demonstrated that 
chromosome missegregation initiates 
tumorigenesis by causing cells to lose 
tumor suppressors like p53 (3). “It’s like a 
self-fulfi  lling prophecy,” argues Compton. 
“If you missegregate a chromosome en-
coding p53, you make the cells defi  cient 
in p53, so they’re able to propagate and 
missegregate more chromosomes.”
Compton points out that there may 
be other pathways that arrest cells after 
chromosome missegregation but, equally 
importantly, there are also circumstances in 
which nontumor cells tolerate aneuploidy 
just fi  ne. Human brain cells are often aneu-
ploid (4), as are early embryos, where 
mitotic fi  delity may be sacrifi  ced in the 
name of speed (5). Tissue context therefore 
seems to affect a cell’s response to changes 
in its chromosome complement.
Nevertheless, in most cases, healthy 
cells keep a tight check on aneuploidy. 
“I think it affects a lot of different path-
ways,” says Compton. “The next question 
to ask is which pathways are sensitive to 
aneuploidy, and how do tumor cells over-
come those problems?”
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Sarah Thompson and Duane Compton 
investigated why, unlike tumor cells, normal 
cells don’t proliferate once they contain an 
abnormal number of chromosomes. The 
researchers introduced a single ﬂ  uorescent 
mark into the genome of a diploid cell line, 
induced missegregation, and identiﬁ  ed  the 
cells that incorrectly carried two or zero 
marks (green) on their DNA (blue). These cells 
arrested due to increased levels of the tumor 
suppressor p53 (purple) and its transcriptional 
target, the cyclin-dependent kinase inhibitor 
p21 (red). The cells could grow and progress 
toward a cancer-like state if missegregation 
was combined with a loss of p53.
“We can 
convert a 
diploid cell into 
something…
that looks like 
a tumor cell.”
Tumor suppressor stops cells from gaining or losing chromosomes.
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